TRPX
Therapix Biosciences Ltd.
TRPX
TRPX
Delisted
TRPX was delisted on the 1st of July, 2020.
6 hedge funds and large institutions have $212K invested in Therapix Biosciences Ltd. in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
–
Holders Change %
0%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Morgan Stanley
New York
|
$160K |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
$35K |
| 3 |
UBS Group
Zurich,
Switzerland
|
$15K |
| 4 |
Barclays
London,
United Kingdom
|
$2K |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $160K | +$134K | +41,448 | +525% |
|
|
OAM
2
Oxford Asset Management
Oxford,
United Kingdom
| $35K | +$35K | +10,709 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $15K | +$9.86K | +3,030 | +192% |
|
|
4
Barclays
London,
United Kingdom
| $2K | +$2K | +681 | New |
|